Bioelectronics Corp (BIEL)

[4toSchool]

The major differences between the failure of Actipatch and Boots and Actipatch and DonJoy is the involvement by AW. AW prematurely pulled the ActiPatch from the Boots shelves. Now, AW can't pull the plug on DonJoy, or any other deal. In addition, BIEL is now relying on DonJoy, a company with stellar sales and marketing skills combined with a market proven product versus AW's belief that the ActiPatch would fly of the shelves without marketing and without partnering with another product.

I'm confident that BIEL will be successful. I just hope that my shares are not diluted by 67%, via the Whelans and their ill-gotten convertible promissory notes.